Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

Continuous evaluation of the coronavirus disease 2019 (COVID-19) vaccine effectiveness in hemodialysis (HD) patients is critical in this immunocompromised patient group with higher mortality rates due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The response towards vac...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Maria Gonzalez-Perez, Jana Baranda, Marcos J. Berges-Buxeda, Patricia Conde, Mayte Pérez-Olmeda, Daniel Lozano-Ojalvo, Carmen Cámara, Maria del Rosario Llópez-Carratalá, Emilio Gonzalez-Parra, Pilar Portolés, Alberto Ortiz, Jose Portoles, Jordi Ochando
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2023-04-01
Seri Bilgileri:	Pharmaceuticals
Konular:	COVID-19 chronic kidney disease hemodialysis SARS-CoV-2 vaccine 1273-mRNA vaccine humoral response
Online Erişim:	https://www.mdpi.com/1424-8247/16/4/574
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

Benzer Materyaller